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Special Programs, Division of Transplantation, Rockville, MD;Organ commerce revisited UNOS, Richmond, VA
2. Chugh KS, Jha V: Commerce in transplantation in Third World
To the Editor: It may be time to revisit the issue of countries. Kidney Int 49:1181–1186, 1996
3. The Gallup Organization, Inc., “The American Public’s Attitudesorgan commerce. Early last September, the U.S. Internet
Toward Organ Donation and Transplantation,” conducted for theauction site eBay closed bidding on a “fully functional Partnership for Organ Donation, Boston, MA, February, 1993
kidney for sale” after it reached $5,750,100. In response 4. Rhodes R: A review of ethical issues in transplantation. Mt Sinai J
Med 61:77–82, 1994to an about.com on-line poll conducted the following
week, 69% of respondents thought it should be legal to
sell one’s own kidney.
In 1998, there were 2,307 deaths on the United Network Comparison of survival data
for Organ Sharing (UNOS) kidney transplant waiting list
To the Editor: In a recent issue of Kidney International[1]. These deaths are due to social obstacles in organ
Arkouche et al compare the survival data of their out-procurement, rather than scientific ones in transplanta-
center patients (AURAL) with other series includingtion.
ours [1].Organ commerce is no new idea. India tried it for twenty
The authors state that their population is comparableyears. In 1996, Kidney International published the article,
to the Tassin population for demography and age. We“Commerce in transplantation in Third World countries”
disagree. The highly selected population treated in self-[2], which details many lessons learned in the absence of
care hemodialysis (HD) they describe is quite differentregulation. Among those, transplant donors were India’s
from the global population we reported about in the twopoorest and least healthy people, while their kidneys at-
articles they refer to, which included over 75% of in-tracted the wealthy from around the world. Intermediaries
center patients. Comparing the AURAL to the Tassincommonly exploited donors by never paying them, and
overall population is misleading due to obvious selectionrecipients never knew what they were getting for their
bias. We have never published our out-center survival datamoney. They often got bad kidneys (records were falsified
(89, 77, 60, and 44% at 5, 10, 15 and 20 years, respectively).to show good HLA matches) and bad infections (for ex-
Furthermore, opposite to usage, the authors describe aample, HIV, hepatitis).
subgroup of 174 patients treated out-center but not ac-A 1993 Gallup poll found that financial incentives would
make 12% of respondents more likely to donate their cepted on the transplant list. This unconventional sub-
own or their family member’s organs, and that “younger group of patients with an “intermediate” risk level (that
respondents [whose organs are more likely to be viable] is, eligible for self-dialysis, but sick/old enough not to be
appear more amenable to financial incentives” [3]. These considered for transplantation) cannot be compared with
12%, coupled with altruistic donations, could reduce other series in terms of survival because such selection
deaths on the waiting list to zero. Perhaps UNOS could criteria have not been used up to now in published reports.
be trusted to screen, buy, and fairly allocate organs, as Arkouche et al must be congratulated for the excellent
Rhodes suggests [4]. outcome their patients achieve, but nothing in their pres-
The Internet is changing the way medicine is practiced ent data allows them to conclude that they achieve a better
and perceived. Telemedicine consultations and a vast ex- survival than others.
panse of medical information is now available to patients.
B. Charra, J.-M. Hurot, C. Chazot, C. VoVan, G. Jean,We need to be sure that patients are asking questions,
J.-C. Terrat, T. Vanel, M. Ruffet, and G. Laurentand because technology and popular views on organ trans-
Tassin, France
plantation may be evolving side by side, we need to do
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We thank Dr. Charra and his colleagues for allowing us
to expand on our out-center hemodialysis survival study [1].
We completely agree on the difficulties to compareÓ 2000 by the International Society of Nephrology
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survival results between different structures. Based on Fortunately, more than 60% who started dialysis within
our units were successfully transplanted, which appearstheir cardinal publication [2], the incidence of the high-
risk etiologies of chronic renal failure (diabetes mellitus, to be a good rate among comparable dialysis units. This,
of course, leads to a higher risk group of remaining di-systemic diseases, nephrosclerosis) was 20% in Tassin
alysis patients. However, survival in this subgroup ap-as compared with 22% in our population. The mean age
pears to be quite good and suggests that even thoseat the start of treatment by hemodialysis increased in
patients could benefit from out-center facilities.Tassin from 36.2 to 52.9 years, and from 31.2 to 52.6
Based on our data, we strongly recommend mainte-years in AURAL. The table shows the age distribution:
nance out-center hemodialysis for selected patients.
Age years
Walid Arkouche, Jules Traeger, Ehsaw Delawari,
,35 35–44 45–54 55–64 .65 Total Roula Sibai-Galland, Elias Abdullah, Roland Galland,
Philippe Leitienne, Denis Fouque, and Maurice Laville
AURAL 136 107 111 87 30 471 Lyon, France
Tassin 112 84 111 98 40 445
Correspondence to Dr. Arkouche, AURAL, 52 Boulevard Pinel 69003
Lyon, France.In addition, we come to know in this letter that about E-mail: arkouche@auralyon.com
25% of the population analyzed by Dr. Charra were treated
in out-center hemodialysis structures, yielding the compari- REFERENCES
son more difficult, and probably worsening their full-care
1. Arkouche W, Traeger J, Delawari E, Sibai-Galland R, Abdul-in-center hemodialysis survival results. Therefore, we sin- lah E, Galland R, Leitienne P, Fouque D, Laville M: Twenty-
five years of experience with out-center hemodialysis. Kidney Int 56:cerely thank Dr. Charra for mentioning their unpublished
2269–2275, 1999out-center hemodialysis survival data that strongly sup-
2. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel
port our conclusions, showing that out-center dialysis T, Laurent G: Survival as an index of adequacy of dialysis. Kidney
Int 41:1286–1291, 1992confers a better prognosis and should be encouraged.
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